Analysis of Rare Variant c.2395C>T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan

The ERCC4 / FANCQ gene is a potential candidate gene for susceptibility to hereditary breast cancer, being a participant of the Fanconi anemia (FA)/BRCA pathway required for DNA repair. ERCC4 encodes XPF endonuclease which mainly participates in nucleotide excision repair (NER) and interstrand cross...

Full description

Saved in:
Bibliographic Details
Published in:Russian journal of genetics 2020-05, Vol.56 (5), p.627-632
Main Authors: Bermisheva, M. A., Gilyazova, I. R., Zinnatullina, G. F., Khusnutdinova, E. K.
Format: Article
Language:English
Subjects:
Animal Genetics and Genomics
Biomedical and Life Sciences
Biomedicine
Human Genetics
Microbial Genetics and Genomics
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c240t-c8f263783820212f1f0c8df9e39b46e4e521ffcee36152947840f4e4ccd809ac3
container_end_page 632
container_issue 5
container_start_page 627
container_title Russian journal of genetics
container_volume 56
creator Bermisheva, M. A.
Gilyazova, I. R.
Zinnatullina, G. F.
Khusnutdinova, E. K.
description The ERCC4 / FANCQ gene is a potential candidate gene for susceptibility to hereditary breast cancer, being a participant of the Fanconi anemia (FA)/BRCA pathway required for DNA repair. ERCC4 encodes XPF endonuclease which mainly participates in nucleotide excision repair (NER) and interstrand crosslink (ICL) repair. Heterozygous mutations in ERCC4 have been identified in various cancers. In this study the heterozygous mutation c.2395C>T (p.Arg799Trp) in ERCC4 was found in a hereditary breast cancer patient using next-generation sequencing. Further screening for the ERCC4 *p.Arg799Trp mutation in 966 breast cancer patients and 686 control individuals revealed heterozygous mutation carriers in both groups, but no statistically significant differences in the frequency of the mutant allele between the two samples were found. The results of our study suggest that the ERCC4 *p.Arg799Trp mutation is not associated with high risk of breast cancer, although further studies are needed to evaluate the clinical significance of this mutation.
doi_str_mv 10.1134/S1022795420050026
format article
fullrecord <record><control><sourceid>crossref_sprin</sourceid><recordid>TN_cdi_crossref_primary_10_1134_S1022795420050026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1134_S1022795420050026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c240t-c8f263783820212f1f0c8df9e39b46e4e521ffcee36152947840f4e4ccd809ac3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EEqXwA9g8wpBy_khiL0htVApSJVAprJFxzyX9cCrbHfrvSVU2JKa70_s-NzyE3DIYMCbkwzsDzkudSw6QA_DijPRYASoTotDn3d7F2TG_JFcxrgAYQCF6ZD30ZnOITaStozMTkH6a0BifqB1wofPqcU7vdoNhWJZaz8PunjaeTtAjHc-qSh6vUUATE62Mtxjom0kN-hSpC-2Wjkz8XrchtTEZf00unNlEvPmdffLxNJ5Xz9n0dfJSDaeZ5RJSZpXjhSiVUBw44445sGrhNAr9JQuUmHPmnEUUBcu5lqWS4CRKaxcKtLGiT9jprw1tjAFdvQvN1oRDzaA-2qr_2OoYfmJi1_VLDPWq3YfOTfwH-gEqEmkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Analysis of Rare Variant c.2395C&gt;T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan</title><source>Springer Nature</source><creator>Bermisheva, M. A. ; Gilyazova, I. R. ; Zinnatullina, G. F. ; Khusnutdinova, E. K.</creator><creatorcontrib>Bermisheva, M. A. ; Gilyazova, I. R. ; Zinnatullina, G. F. ; Khusnutdinova, E. K.</creatorcontrib><description>The ERCC4 / FANCQ gene is a potential candidate gene for susceptibility to hereditary breast cancer, being a participant of the Fanconi anemia (FA)/BRCA pathway required for DNA repair. ERCC4 encodes XPF endonuclease which mainly participates in nucleotide excision repair (NER) and interstrand crosslink (ICL) repair. Heterozygous mutations in ERCC4 have been identified in various cancers. In this study the heterozygous mutation c.2395C&gt;T (p.Arg799Trp) in ERCC4 was found in a hereditary breast cancer patient using next-generation sequencing. Further screening for the ERCC4 *p.Arg799Trp mutation in 966 breast cancer patients and 686 control individuals revealed heterozygous mutation carriers in both groups, but no statistically significant differences in the frequency of the mutant allele between the two samples were found. The results of our study suggest that the ERCC4 *p.Arg799Trp mutation is not associated with high risk of breast cancer, although further studies are needed to evaluate the clinical significance of this mutation.</description><identifier>ISSN: 1022-7954</identifier><identifier>EISSN: 1608-3369</identifier><identifier>DOI: 10.1134/S1022795420050026</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Animal Genetics and Genomics ; Biomedical and Life Sciences ; Biomedicine ; Human Genetics ; Microbial Genetics and Genomics</subject><ispartof>Russian journal of genetics, 2020-05, Vol.56 (5), p.627-632</ispartof><rights>Pleiades Publishing, Inc. 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c240t-c8f263783820212f1f0c8df9e39b46e4e521ffcee36152947840f4e4ccd809ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bermisheva, M. A.</creatorcontrib><creatorcontrib>Gilyazova, I. R.</creatorcontrib><creatorcontrib>Zinnatullina, G. F.</creatorcontrib><creatorcontrib>Khusnutdinova, E. K.</creatorcontrib><title>Analysis of Rare Variant c.2395C&gt;T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan</title><title>Russian journal of genetics</title><addtitle>Russ J Genet</addtitle><description>The ERCC4 / FANCQ gene is a potential candidate gene for susceptibility to hereditary breast cancer, being a participant of the Fanconi anemia (FA)/BRCA pathway required for DNA repair. ERCC4 encodes XPF endonuclease which mainly participates in nucleotide excision repair (NER) and interstrand crosslink (ICL) repair. Heterozygous mutations in ERCC4 have been identified in various cancers. In this study the heterozygous mutation c.2395C&gt;T (p.Arg799Trp) in ERCC4 was found in a hereditary breast cancer patient using next-generation sequencing. Further screening for the ERCC4 *p.Arg799Trp mutation in 966 breast cancer patients and 686 control individuals revealed heterozygous mutation carriers in both groups, but no statistically significant differences in the frequency of the mutant allele between the two samples were found. The results of our study suggest that the ERCC4 *p.Arg799Trp mutation is not associated with high risk of breast cancer, although further studies are needed to evaluate the clinical significance of this mutation.</description><subject>Animal Genetics and Genomics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Human Genetics</subject><subject>Microbial Genetics and Genomics</subject><issn>1022-7954</issn><issn>1608-3369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EEqXwA9g8wpBy_khiL0htVApSJVAprJFxzyX9cCrbHfrvSVU2JKa70_s-NzyE3DIYMCbkwzsDzkudSw6QA_DijPRYASoTotDn3d7F2TG_JFcxrgAYQCF6ZD30ZnOITaStozMTkH6a0BifqB1wofPqcU7vdoNhWJZaz8PunjaeTtAjHc-qSh6vUUATE62Mtxjom0kN-hSpC-2Wjkz8XrchtTEZf00unNlEvPmdffLxNJ5Xz9n0dfJSDaeZ5RJSZpXjhSiVUBw44445sGrhNAr9JQuUmHPmnEUUBcu5lqWS4CRKaxcKtLGiT9jprw1tjAFdvQvN1oRDzaA-2qr_2OoYfmJi1_VLDPWq3YfOTfwH-gEqEmkQ</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Bermisheva, M. A.</creator><creator>Gilyazova, I. R.</creator><creator>Zinnatullina, G. F.</creator><creator>Khusnutdinova, E. K.</creator><general>Pleiades Publishing</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200501</creationdate><title>Analysis of Rare Variant c.2395C&gt;T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan</title><author>Bermisheva, M. A. ; Gilyazova, I. R. ; Zinnatullina, G. F. ; Khusnutdinova, E. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c240t-c8f263783820212f1f0c8df9e39b46e4e521ffcee36152947840f4e4ccd809ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animal Genetics and Genomics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Human Genetics</topic><topic>Microbial Genetics and Genomics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bermisheva, M. A.</creatorcontrib><creatorcontrib>Gilyazova, I. R.</creatorcontrib><creatorcontrib>Zinnatullina, G. F.</creatorcontrib><creatorcontrib>Khusnutdinova, E. K.</creatorcontrib><collection>CrossRef</collection><jtitle>Russian journal of genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bermisheva, M. A.</au><au>Gilyazova, I. R.</au><au>Zinnatullina, G. F.</au><au>Khusnutdinova, E. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of Rare Variant c.2395C&gt;T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan</atitle><jtitle>Russian journal of genetics</jtitle><stitle>Russ J Genet</stitle><date>2020-05-01</date><risdate>2020</risdate><volume>56</volume><issue>5</issue><spage>627</spage><epage>632</epage><pages>627-632</pages><issn>1022-7954</issn><eissn>1608-3369</eissn><abstract>The ERCC4 / FANCQ gene is a potential candidate gene for susceptibility to hereditary breast cancer, being a participant of the Fanconi anemia (FA)/BRCA pathway required for DNA repair. ERCC4 encodes XPF endonuclease which mainly participates in nucleotide excision repair (NER) and interstrand crosslink (ICL) repair. Heterozygous mutations in ERCC4 have been identified in various cancers. In this study the heterozygous mutation c.2395C&gt;T (p.Arg799Trp) in ERCC4 was found in a hereditary breast cancer patient using next-generation sequencing. Further screening for the ERCC4 *p.Arg799Trp mutation in 966 breast cancer patients and 686 control individuals revealed heterozygous mutation carriers in both groups, but no statistically significant differences in the frequency of the mutant allele between the two samples were found. The results of our study suggest that the ERCC4 *p.Arg799Trp mutation is not associated with high risk of breast cancer, although further studies are needed to evaluate the clinical significance of this mutation.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S1022795420050026</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1022-7954
ispartof Russian journal of genetics, 2020-05, Vol.56 (5), p.627-632
issn 1022-7954
1608-3369
language eng
recordid cdi_crossref_primary_10_1134_S1022795420050026
source Springer Nature
subjects Animal Genetics and Genomics
Biomedical and Life Sciences
Biomedicine
Human Genetics
Microbial Genetics and Genomics
title Analysis of Rare Variant c.2395C>T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A38%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20Rare%20Variant%20c.2395C%3ET%20(p.Arg799Trp)%20in%20Gene%20ERCC4%20in%20Breast%20Cancer%20Patients%20from%20Bashkortostan&rft.jtitle=Russian%20journal%20of%20genetics&rft.au=Bermisheva,%20M.%20A.&rft.date=2020-05-01&rft.volume=56&rft.issue=5&rft.spage=627&rft.epage=632&rft.pages=627-632&rft.issn=1022-7954&rft.eissn=1608-3369&rft_id=info:doi/10.1134/S1022795420050026&rft_dat=%3Ccrossref_sprin%3E10_1134_S1022795420050026%3C/crossref_sprin%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c240t-c8f263783820212f1f0c8df9e39b46e4e521ffcee36152947840f4e4ccd809ac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true